Category: Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-03-27

March 27, 2024August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has extended both the contract period and the confidentiality withholding deadline for disclosing its counterparty regarding a KRW 154.1B letter of intent (LOI) for a biopharmaceutical contract manufacturing agreement to June 30, 2024, following consultations with the client. 📊 [Key Disclosure Details & Financial…

Disclosures, Bio & Healthcare

[Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26

March 26, 2024August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron disclosed the additional listing of 4,062,321 common shares resulting from the conversion of its 16th domestic private convertible bonds (CB), scheduled for listing on March 29, 2024. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Disclosures, Semiconductors

[Disclosure] LEENO Industrial (058470) – Results of Annual General Meeting of Shareholders / 2024-03-26

March 26, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary At LEENO Industrial’s 28th Annual General Meeting of Shareholders, all proposed agenda items were approved as originally submitted, including the approval of financial statements, a cash dividend of KRW 3,000 per common share, and the re-election of Executive Director Chae-Yoon Lee. 📊 [Key Disclosure Details &…

Disclosures, Semiconductors

[Disclosure] ALTEOGEN (196170) – Results of Annual General Meeting of Shareholders / 2024-03-26

March 26, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary At the 16th Annual General Meeting of Shareholders held on March 26, 2024, all proposed agendas—including approval of financial statements, appointment of directors and auditor, approval of remuneration limits, and granting of stock options—were approved as originally submitted. 📊 [Key Disclosure Details & Financial Highlights] 📝…

Bio & Healthcare, Disclosures

[Disclosure] Celltrion (068270) – Results of Annual General Meeting of Shareholders / 2024-03-26

March 26, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that all agenda items presented at its 33rd Annual General Meeting of Shareholders, including the approval of financial statements, a cash dividend of KRW 500 per common share, and the re-appointment of Inside Director Jin-Seok Seo, were approved as original proposals. 📊 [Key Disclosure…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Decision on Cash/In-Kind Dividend (Correction) / 2024-03-26

March 26, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion disclosed a correction to its FY2023 year-end cash dividend, updating the total dividend amount to approximately KRW 103.6B (KRW 500 per share) following changes in eligible shares and the confirmation of the AGM date. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Results of Annual General Meeting of Shareholders / 2024-03-26

March 26, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary At its 47th Annual General Meeting of Shareholders, Hanwha Aerospace approved all original agenda items, including financial statements, a cash dividend of KRW 1,800 per common share (totaling approx. KRW 91.02B), partial amendments to the Articles of Incorporation, and board elections. 📊 Key Disclosure Contents &…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations / 2024-03-26

March 26, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace decided to participate in a rights offering to acquire 1,064,302 shares of its affiliate, Hanwha Precision Machinery Co., Ltd., for approximately KRW 170.00B to expand its semiconductor process equipment business. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Decision on Paid-in Capital Increase / 2024-03-26

March 26, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace’s wholly owned subsidiary, Hanwha Precision Machinery Co., Ltd., decided on a shareholder-allocated rights offering worth approximately KRW 170.00B to raise facility capital for expanding its semiconductor process equipment business. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Disclosures, Defense

[Disclosure] KEPCO (015760 / KEP) – Results of Annual General Meeting of Shareholders / 2024-03-26

March 26, 2024August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO held its 63rd Annual General Meeting of Shareholders on March 26, 2024, approving the FY2023 financial statements and the 2024 remuneration limit for directors as originally proposed. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Energy